Mahalaxmi Bioscience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 132.87%
- Profit Growth -34.82%
- Ebitda -623.06%
- Net Worth 25.56%
- Total Assets 106.31%
About Mahalaxmi Bioscience
Mahalaxmi Bioscience Private Limited (MBPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 September 2016 (Eight years and five months 16 days old ). Its registered office is in Sabarkantha, Gujarat, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dineshbhai Patel and Dhirubhai Patel serve as directors at the Company.
Company Details
- Location
Sabarkantha, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999GJ2016PTC093635
- Company No.
093635
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Mahalaxmi Bioscience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhirubhai Patel  | Director | 07-Sep-2016 | Current |
| Dineshbhai Patel | Director | 07-Sep-2016 | Current |
Financial Performance of Mahalaxmi Bioscience.
Mahalaxmi Bioscience Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 132.87% increase. The company also saw a substantial fall in profitability, with a 34.82% decrease in profit. The company's net worth Soared by an impressive increase of 25.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mahalaxmi Bioscience?
In 2018, Mahalaxmi Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ma Laxmi Seeds Private LimitedDineshbhai Patel and Dhirubhai Patel are mutual person
- Mahalaxmi Cropscience Private Limited
Dineshbhai Patel is a mutual person
- Seedmen Association North Gujarat
Dineshbhai Patel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mahalaxmi Bioscience?
Unlock and access historical data on people associated with Mahalaxmi Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mahalaxmi Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahalaxmi Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.